This study tested a new inhaled medication called opelconazole (PC945) to prevent a serious fungal lung infection (aspergillosis) in people who had a lung transplant. The trial included 102 participants and compared the safety and tolerability of the new drug against standard car…
Phase: PHASE2 • Sponsor: Pulmocide Ltd • Aim: Prevention
Last updated May 15, 2026 11:55 UTC